Peptide Comparison Table

Last updated: June 2026

About this reference table

Below is the structural chemistry reference for every research peptide and laboratory compound currently stocked by Australian Peptide Hub. Each row links to the product page for full background, certificate of analysis access, and ordering. Where a value differs between published sources, that value has been withheld pending consensus across at least three independent references.

The table is intended as a quick lookup for researchers cross-referencing a compound against the wider literature (PubChem, ChEBI, ChemSpider, peer-reviewed assay reports).

Compound Class Molecular formula MW (g/mol) CAS PubChem CID Sequence / composition Vial sizes
BPC-157 Pentadecapeptide (15-residue) C62H98N16O22 1419.5 137525-51-0 9941957 GEPPPGKPADDAGLV 10 mg
TB-500 Acetylated 43-residue peptide C212H350N56O78S 4963.4 77591-33-4 16132341 Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH 10 mg
GHK-Cu Tripeptide-copper(II) complex C14H24CuN6O4 ~403.9 89030-95-5 378611 Gly-His-Lys (Cu²⁺ coordinated) 50 mg, 100 mg
Ipamorelin Pentapeptide amide (5-residue) C38H49N9O5 711.9 170851-70-4 20754357 Aib-His-D-2-Nal-D-Phe-Lys-NH2 5 mg, 10 mg
KPV Tripeptide C16H30N4O4 342.43 67727-97-3 125672 Lys-Pro-Val (α-MSH C-terminal) 10 mg
Semax Heptapeptide (7-residue) C37H51N9O10S 813.93 80714-61-0 122178 Met-Glu-His-Phe-Pro-Gly-Pro 11 mg
Selank Heptapeptide (7-residue) C33H57N11O9 751.89 129954-34-3 11765600 Thr-Lys-Pro-Arg-Pro-Gly-Pro 5 mg
Kisspeptin-10 Decapeptide amide (10-residue) C63H83N17O14 1302.44 374675-21-5 25240297 YNWNSFGLRF-NH2 10 mg
Thymosin Alpha-1 Acetylated 28-residue peptide C129H215N33O55 3108.31 62304-98-7 16130571 Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH 10 mg
Tesamorelin Modified 44-residue GHRH analogue C221H366N72O67S 5135.86 218949-48-5 16137828 trans-3-hexenoyl-GHRH(1-44) 10 mg
Cagrilintide Lipidated 37-residue amylin analogue C194H312N54O59S2 ~4409 1415456-99-3 171397054 Lipidated 37-residue polypeptide 5 mg
Melanotan-I Tridecapeptide (acetylated, amidated) C78H111N21O19 1646.85 75921-69-6 16154396 Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 10 mg
MOTS-c Mitochondrial 16-residue peptide C101H152N28O22S2 2174.6 1627580-64-6 146675088 MRWQEMGYIFYPRKLR 10 mg, 40 mg
SS-31 (Elamipretide) Tetrapeptide amide (mitochondrial) C32H49N9O5 639.80 736992-21-5 11764719 D-Arg-Dmt-Lys-Phe-NH2 10 mg
Retatrutide Lipidated 39-residue triple agonist C221H342N46O68 4731.33 2381089-83-2 withheld (consensus pending) Lipidated 39-residue polypeptide 10 mg, 15 mg, 20 mg, 30 mg
Tirzepatide Lipidated 39-residue dual agonist C225H348N48O68 4813.45 2023788-19-2 166567236 Lipidated 39-residue polypeptide 10 mg, 20 mg, 30 mg, 60 mg
Glutathione (GSH) Tripeptide (γ-glutamyl) C10H17N3O6S 307.32 70-18-8 124886 γ-Glu-Cys-Gly 1500 mg
Adamax Adamantane-modified peptide (Semax analogue) withheld (consensus pending) withheld withheld withheld Ac-MEHFPGP-AG-NH2 with adamantane group (9 residues) 5 mg
NAD+ Nucleotide cofactor (dinucleotide) C21H27N7O14P2 663.43 53-84-9 5893 n/a (not a peptide) 1000 mg
SLU-PP-332 Small molecule (ERR agonist) C18H14N2O2 290.32 303760-60-3 5338394 n/a (not a peptide) 5 mg
BPC-157 + TB-500 2-peptide co-lyophilised blend blend (see components) blend 137525-51-0 + 77591-33-4 9941957 + 16132341 10 mg BPC-157 + 10 mg TB-500 per vial 20 mg
CJC-1295 + Ipamorelin 2-peptide co-lyophilised blend blend (see components) blend 863288-34-0 + 170851-70-4 56841945 + 20754357 5 mg CJC-1295 (no-DAC) + 5 mg Ipamorelin per vial 10 mg
GLOW 3-peptide co-lyophilised blend blend (see components) blend 89030-95-5, 137525-51-0, 77591-33-4 73587, 9941957, 16132341 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 per vial 70 mg
KLOW 4-peptide co-lyophilised blend blend (see components) blend 89030-95-5, 137525-51-0, 77591-33-4, 67727-97-3 73587, 9941957, 16132341, 125672 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV per vial 80 mg
Bacteriostatic Water Sterile laboratory solvent H2O + 0.9% benzyl alcohol n/a 100-51-6 (benzyl alcohol) 244 (benzyl alcohol) USP-grade sterile water with 0.9% benzyl alcohol preservative 3 mL, 10 mL

Reading the table

Molecular formula uses standard subscript notation. MW is the calculated monoisotopic or average molecular weight in grams per mole as published in the primary literature; values reflect the free peptide unless a salt form is specified on the product page. CAS and PubChem CID point to the authoritative chemistry record where one exists. Sequence / composition shows the one-letter or three-letter amino-acid sequence for single-component peptides; for blends, the per-vial component composition is shown. Vial sizes lists the lyophilised mass options stocked in our Australian warehouse.

Where a value reads “withheld (consensus pending)”, sources across published references and supplier specifications disagreed at the time of publication. Each published value reflects agreement across at least three independent references. The blank cell is a deliberate filter applied per our chemistry-verification policy.

Where this data comes from

Each row’s chemistry has been cross-checked against PubChem, ChemSpider, peer-reviewed assay literature, and supplier certificates of analysis. Where a discrepancy was found, the more recent peer-reviewed source took precedence. For blends, the per-component data follows the single-compound row exactly. See the certificate of analysis explainer for what each parameter on the COA means.

Common cross-references

  • PubChem (pubchem.ncbi.nlm.nih.gov) is the National Library of Medicine’s open chemistry database. Each CID resolves to a canonical record with SMILES, InChI, computed properties, and literature links.
  • CAS (Chemical Abstracts Service) numbers are the universally accepted identifiers for chemical substances in laboratory inventory systems and safety data sheets.
  • ChEBI and ChemSpider hold complementary records; PubChem CID is the most stable cross-reference key for laboratory automation.

Regulatory & Use Disclaimer

The products listed on this site are supplied exclusively for in-vitro laboratory and scientific investigation purposes. They are not for human or veterinary use, therapeutic application, or diagnostic purposes. No therapeutic, dosage, or outcome statements are made or implied. Australian researchers are responsible for ensuring compliance with all applicable laws and regulations regarding research peptides.